Andrea Casazza
Seminars
Thursday 12th November 2026
RNA Methyltransferase Inhibition Validates Epitranscriptomic Regulation as a Novel Approach in the Treatment of Solid Tumors
3:00 pm
- Positioning RNA epitranscriptomics as a novel small molecule modality for cancer therapy
- Exploring methyltransferase inhibition as a means to alter tumour cell phenotype and limit cancer adaptability
- Mechanisms underlying the pharmacology of METTL3 inhibition across tumor types
